Global Cardiac Biomarkers Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Cardiac Biomarkers Market 2024 by Company, Regions, Type and Application, Forecast to 2030

According to our (Global Info Research) latest study, the global Cardiac Biomarkers market size was valued at USD 724.6 million in 2023 and is forecast to a readjusted size of USD 1310.7 million by 2030 with a CAGR of 8.8% during review period.

Cardiovascular diseases are leading cause of morbidity and mortality globally. Biomarkers are generally used as an indicator forparticular diseases such as rheumatic and congenital heart diseases and cardiac arrhythmia. Cardiac biomarkers are measurable and quantifiable biological parameters. These are specifically used to check the presence or severity of cardiovascular diseases. Cardiac biomarkers are the substances that are released into blood when heart is damaged. These biomarkers are also used for diagnosing and monitoring diseases such as coronary syndrome or cardiac ischemia. The symptoms of these diseases includes chest pain, shortness of breath and nausea that ultimately leads to heart attack or angina. Cardiac biomarker tests helps to detect presence of coronary syndrome and cardiac ischemia to evaluate its severity and diagnosis.

The prevention of cardiac diseases by monitoring the heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment. Cardiac biomarkers are protein-based traceable substances used as an indicator of biologic state and used for diagnostic and prognostic purposes associated with heart. Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infraction, congestive heart failure, acute coronary syndrome (ACS) among others. The cardiac biomarkers that are widely used as an integrated diagnostic approach for CVDs include CK-MB, troponin I and T, myoglobin, BNPs, IMA and few others. Cardiac biomarkers market has witnessed a greater demand over the past five to six years. 

The Global Info Research report includes an overview of the development of the Cardiac Biomarkers industry chain, the market status of Acute Coronary Syndrome (Troponin, CK-MB), Myocardial Infarction (Troponin, CK-MB), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cardiac Biomarkers.

Regionally, the report analyzes the Cardiac Biomarkers markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cardiac Biomarkers market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Cardiac Biomarkers market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cardiac Biomarkers industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Troponin, CK-MB).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cardiac Biomarkers market.

Regional Analysis: The report involves examining the Cardiac Biomarkers market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cardiac Biomarkers market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Cardiac Biomarkers:

Company Analysis: Report covers individual Cardiac Biomarkers players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cardiac Biomarkers This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Acute Coronary Syndrome, Myocardial Infarction).

Technology Analysis: Report covers specific technologies relevant to Cardiac Biomarkers. It assesses the current state, advancements, and potential future developments in Cardiac Biomarkers areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cardiac Biomarkers market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Cardiac Biomarkers market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
Troponin
CK-MB
Natriuretic Peptides - BNP and NT-proBNP
Myoglobin
Others

Market segment by Application
Acute Coronary Syndrome
Myocardial Infarction
Congestive Heart Failure
Others

Market segment by players, this report covers
Abbott
Abbott
F. Hoffmann-La Roche
Advanced ImmunoChemical
AgPlus Diagnostics
BG Medicine
BioLegend
bioMérieux
Bio-Rad Laboratories
BODITECH MED

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Cardiac Biomarkers product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Cardiac Biomarkers, with revenue, gross margin and global market share of Cardiac Biomarkers from 2019 to 2024.

Chapter 3, the Cardiac Biomarkers competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cardiac Biomarkers market forecast, by regions, type and application, with consumption value, from 2025 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Cardiac Biomarkers.

Chapter 13, to describe Cardiac Biomarkers research findings and conclusion.